ONLINE CARDIOVASCULAR RISK MASTER CLASS

An educational alliance to optimize management of cardiovascular disease: Applying new insights to clinical practice
 
The Master Class program is a global initiative of the Physicians’ Academy for Cardiovascular Education(PACE) foundation with a particular focus on issues and opportunities in cardiovascular risk and lipid management in high risk patients.
   
The Master Class will be broadcasted live. 
Physicians not able to participate will be able to be part of this interactive meeting.


 

Register for live online access

 

Traducción Español

 

Regístrese para tener acceso

 

 

Faculty

• Prof. John Deanfield, London, United Kingdom
• Prof. John Betteridge, London, United Kingdom
• Prof Raul Santos, Sao Paolo, Brazil
• Prof. Luis Ruilope, Madrid, Spain
• Dr. Kees Hovingh, Amsterdam, the Netherlands

 

This CV Risk Master Class will be a dynamic meeting with state of the art lectures, clinical debates, and practical workshops. Participants will be part of an educational initiative that will provide support to clinicians in their daily clinical management of cardiovascular risk and diabetes. The program provides an optimal balance between updates in forefront science and clinical dialogue, with involvement of international and regional thought leaders.
 
Participants will not only be educated on the new science and clinical perspective in lipid and CV risk management but also engage in educational activities. Therefore a part of the master class will be dedicated on specific support and educational tools for facilitation of regional medical education initiatives. Teaching resources will become  available on the PACE website.

The meeting will be held at November 1- 2 november 2013

Friday,        - 15:00 - 20:00 hrs (Timezone:(GMT -05.00)
Saturday,    -  08:30 - 14:00 hrs (Timezone:(GMT -05.00)
 

Scientific agenda

The challenge for CV Risk management in Latin America: What are the key opportunities?
Raul Santos MD - Rio de Janeiro, Brazil

Call for action to Prevent CV disease in Latin America: New strategies for early intervention
John Deanfield MD, UCL, London, United Kingdom

Latest insights from clinical trials: The unassailable case for LDL-c lowering & statin therapy
Kees Hovingh MD, Academic Medical Centre, Amsterdam, The Netherlands
 
Macrovascular Disease in diabetes; Opportunities for lipid management
John Betteridge MD, University College London, United Kingdom

Blood pressure lowering and the prevention of CV disease & stroke
Luis Ruilope,MD, Madrid, Spain

The kidney & statin therapy: Friend or Foe?
Kees Hovingh MD, Amsterdam,The Netherlands

Update on new CV Risk guidelines: an international perspective
John Deanfield MD, UCL, London, United Kingdom
 
CV Risk & Lipid Education: How to convey your message most appropriately – Lessons from experience
John Betteridge MD, John Deanfield, MD

The conferences are sponsored by an unrestricted educational grant provided by Pfizer